Patents by Inventor Curtis Ruegg

Curtis Ruegg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND KITS FOR TOPICAL APPLICATION, REMOVAL, AND INACTIVATION OF THERAPEUTIC OR COSMETIC TOXIN COMPOSITIONS
    Publication number: 20210189326
    Abstract: This invention related to methods and kits for safely removing and inactivating topical therapeutic or cosmetic compositions. The methods and kits according to the invention are particularly well suited for removing and inactivating highly toxic substances.
    Type: Application
    Filed: December 7, 2020
    Publication date: June 24, 2021
    Applicant: REVANCE THERAPEUTICS, INC.
    Inventors: JACOB WAUGH, Curtis Ruegg
  • METHODS AND KITS FOR TOPICAL APPLICATION, REMOVAL, AND INACTIVATION OF THERAPEUTIC OR COSMETIC TOXIN COMPOSITIONS
    Publication number: 20140154237
    Abstract: This invention relates to methods and kits for safely removing and inactivating topical therapeutic or cosmetic compositions. The methods and kits according to the invention are particularly well suited for removing and inactivating highly toxic substances.
    Type: Application
    Filed: December 22, 2011
    Publication date: June 5, 2014
    Applicant: REVANCE THERAPEUTICS, INC.
    Inventors: Jacob Waugh, Curtis Ruegg
  • Device and Method for Topical Application of Therapeutics or Cosmetic Compositions
    Publication number: 20110106021
    Abstract: This invention relates to devices and methods for safely reconstituting and administering topical therapeutic or cosmetic compositions. The topical applicator according to the invention is particularly well suited for storing, reconstituting, and administering or applying highly toxic substances.
    Type: Application
    Filed: October 25, 2010
    Publication date: May 5, 2011
    Applicants: Revance Therapeutics, Inc., Duoject Medical Systems, Inc.
    Inventors: Curtis Ruegg, David Reynolds, Daniel MacDonald, Yan Tremblay
  • Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
    Publication number: 20060147520
    Abstract: Microparticles comprising iloprost are disclosed. In some embodiments, the microparticles are used to treat pulmonary hypertension. Devices comprising the microparticles are also disclosed. Combination therapies utilizing the microparticles are also provided.
    Type: Application
    Filed: July 26, 2005
    Publication date: July 6, 2006
    Inventor: Curtis Ruegg
  • Method of producing membrane vesicles
    Publication number: 20040241176
    Abstract: The present invention relates to methods of preparing biological material, for use in various experimental, diagnostic or therapeutic uses, including immunotherapy treatment or prophylaxy of tumors. More particularly, the present invention relates to methods of preparing membrane vesicles (in particular exosomes) released by various types of mammalian cells, comprising diafiltration and/or density cushion centrifugation. The invention also provides novel methods for characterizing and analyzing exosome preparations, which can be used in quality control assay for the purpose of pharmaceutical product production. The invention is suitable to produce pharmaceutical grade preparations of such membrane vesicles and to fully characterize said preparations, for use in human beings.
    Type: Application
    Filed: February 9, 2001
    Publication date: December 2, 2004
    Applicant: AP CELLS. INC.
    Inventors: Henry Lamparski, Curtis Ruegg, Jean-Bernard Le-Pecq, Di-Hewi Hsu, Jenq-Yuan Yao
  • Methods of producing membrane vesicles
    Patent number: 6812023
    Abstract: The present invention relates to methods of preparing biological material, for use in various experimental, diagnostic or therapeutic uses, including immunotherapy treatment or prophylaxy of tumors. More particularly, the present invention relates to methods of preparing membrane vesicles (in particular exosomes) released by various types of mammalian cells, comprising diafiltration and/or density cushion centrifugation. The invention also provides novel methods for characterizing and analyzing exosome preparations, which can be used in quality control assay for the purpose of pharmaceutical product production. The invention is suitable to produce pharmaceutical grade preparations of such membrane vesicles and to fully characterize said preparations, for use in human beings.
    Type: Grant
    Filed: April 27, 2000
    Date of Patent: November 2, 2004
    Assignee: Anosys, Inc.
    Inventors: Henry Lamparski, Curtis Ruegg, Jean-Bernard Le Pecq, Di-Hewi Hsu, Jenq Yuan Yao